Gene list
Applied filters:
COG category: Transcription
Organism: Wolinella succinogenes DSM 1740, DSMZ 1740
Gene type: CDS
Number of genes found: 95
Show UniProt / TrEMBL protein name | View in Fasta format (DNA) | View as list | ||||
# Wolinella succinogenes DSM 1740, DSMZ 1740 >WS0767 Transcription Regulator Protein MKKSELTPRAMARYDKILDAACEVFLEQGFEKASVNEIVKRAGGSLATLY KLFGNKENLFEAILERKSEAIFAELEEEAKASEEQDLESFLWRFGMKFFD MLAKCDSVAMVRILMAEGSRNEGKLGKIFYRHGPGKSEAILERFLRKEHI KGKIAIEDIALAAARFIFLVKEPFHFRSIALGHPMNLSLEERQRVVGEAI HIFLYGITKRSN >WS1109 PROBABLE TRANSCRIPTIONAL REGULATOR MHTMLQEYRLDIAKELLVRGDLSVAEVAKRVGYSSLSHFGKIFHERFGLL PRELKRG >WS0853 PUTATIVE TWO-COMPONENT REGULATOR MKSLKRFNLLFLEDNETFARHMLELLSRFFAQVFHAKSMKGALELLEREK IHAILSDIRIEDGNALEFISKIRQQDTHIPITVLSAHKDEDFLLKAIPLG LGEYLIKPVEFEVLMASLGRMAEALDRLYGRVECFGENLGFYKEERVVIK GEERCPLTPSEARLLELLLAHRGRVLSKEQLEEWLYPEGVVSDSALKNLV LRLRKKIGQESIENIPQIGYKISK >WS2203 PUTATIVE TRANSCRIPTIONAL REGULATOR (LYSR FAMILY) , MRLRELELFLDLLATKSLTQSAERLGMSQPNASHLLSKLEEKGGSKLFDR SGKRLLPLSSALFLEPRAKEIVRLWREAQEELLDQSSLCGELRIAATHTI GEYLLPEILFEFRQTHPKVHLQARIHNTAECLEALLGGEVEQAFIEGETE DNQGVMKRFLRRDELAVVTSDEGLAARARYIDELFDRPWILREKGSGMRD AFLREVVDVKESFPLFLELDRSEAIKRLIQSHGALGCLSLLSVQREIKEG RLFRVEIIGREFWRHFYEVRREGSLGRLAKVFGEFVSVRLSESD >WS0958 hypothetical protein MEHNKVKQIILEAFEKTPELSISKLVANTFIAKRTVQRYVDELIQENRLI ALGQGRSRYYQRVYVNEETLTRLAVLKNGSHMGTLIFANGHYEFVYEKGY EDLLFGISSTHNSSGELYAIFENLIPEHDRRERLTRGFKELGSILVGLDN AHGDFKFIPLGELFKHKSPLEQRPSWLENKHKILGVNEYPNIIQAKVSID EDVLNDTSSTEHSNLSGYQHKIDVDFEDNEIKESAHRAHYLLKPLNRTLT NYFEKDEANHANYYPFLALNEHLFMSFAKKVYCH >WS1734 hypothetical protein MESRDLKVMLKQAGLSKKEFAQIVGLSQQTVSNWGCSKNIPRWVESWLEL YIDSRRFRELKQQFQEMGICHFVEEGRRI >WS0011 PUTATIVE TWO-COMPONENT REGULATOR MKILLLEDDYNYKESIKELLLSLGYEVDDFLSGDEALEAAFHNSYDLLLL DIRVPGIDGYGIVKEVRSYGLKVPVIFITSLTDVNNLSLGYELGCNDYIR KPFSLKELKYRVEEAIRSYHFHSVSPQVQLPCGFIFEINSGILRHEDHEI ALSDKERRVIGLLVKNLDTFMDVDTIREYAWEGKEVGDNDIRMVIKKIRS KTSKEFIQSQRGVGYKIAKE >WS0510 STAGE 0 SPORULATION PROTEIN J MMAAKKSLALGRGLGAILGEVEKAYENDLNDNSDLVVELDIHSIKPNPFQ PRKHFDTTALEELASSIKEHGLLQPILVFADDEEGYSLIAGERRLRASKL AGFSTIKAIIVDIKTERLREVALIENIQREDLNPIDLAQSYKELIEDYGI THEELAKKISKSRTQITNTLRLLTLSLEVQEQLLEGKITQGHAKVLVGLA SEEQKVALDSIIGQRLSVRETESLIKNLKETPRPSSHPSRTPSNPLVSQS SQSLLELVMLMKQKGFKASLKGTKIVLDFEGEEEVKRLIKSLSSLSF >WS0694 hypothetical protein MRGFCKMMFCSDGIYEGRLMEGGIYGASHLAEDFARSSSLREMIQLYKSR VPRQEDDLTMIYCQKITETLKEEERDEIPSTPEGIERGVEKFYKYLMNFN FTPPEMESLKSAFFEVLINAIEHGHMGISYADKVRLKRQRGYDSFLNKKF QEVEIANKKIMVYYSQVKISRASWLLWCIEDEGEGFEVNEVFKSIRLALG KEYCGRGLLMAKELSDGLYYNEKGNRAYLLKRLK >WS0900 PUTATIVE TWO-COMPONENT REGULATOR MKILLLEDDILLNEAITQYLSSAGHSISSVRDGDVCLKILEREAFDLLVF DINVPNIDGLTILATLHEQKKMIPVIFISTLIDIEDISRAFELGCFDYLK KPFHLKELSLRIDRISQAIQVQRKHKRLSASYGFNCENQTLYFNNEPQVL SKRQSQIIEFLAHNRGVVCSYEMFMEDVWSDVEVDVATIRAEINRLKNNL KEDFIINIRRVGYMVKIPR >WS1621 FIBRONECTIN/FIBRINOGEN-BINDING PROTEIN MNLSLLRRFSEQLASHQTLVNLKRTGDNLFKLECDNALYYIDLTRGRSTA FIAPPLFGMKQYQAPFDLSLQRYAARANILWARVEGGNRILQIGLENRGS YKSLRSILQLEFTGRNTNAILLDEAGVVIDALRHIGNERSFREVKIGQKL DSLPEPSKPLAERALPEGLGIQELLEMEYQKRLERELLERQKGAILSIEK KRERLLLSLSQITNEEELAQEAKRLRGQGALLLANLYKLSSFSSCVKLES QEGEVSLEMPPLARSFSEAAQIFFESSKKLEQKAKNLHIEREMLEDKILF YNRQIALIKAAKSVEDVMILAPKKQRAFKSEEKKEEFESFFIEGVKVSFG KNERENVKLLQSAKAEDTWLHVRDIPSSHMILRGGKGKIHANILQKAAEI LVGFLDVSGGNYWVDFTKRKFVKITEGAQVVYAKHETITVKKE >WS0849 TWO-COMPONENT HYBRID SENSOR AND REGULATOR , MSHKPTILVIDDTESNLDMLMAILKNYDVIPALSGKEALEIVKNEKIDLI LLDIMMPEMDGYEVCRRLKSEEATRSIPIIFITAKTDEESIELGYSIGGI DYVTKPFKPRELLARAKTQLDLKGYQESLEAQVESEISQRLAQEKMLIQN AKLAEMGEMMGAIAHQWKQPISAISLFVMNLESEAEQGKLSLDSLREMVS KINHQLLFLSETIDDFRHFFKPDKERVLFDLKDEVKRVIDILAPQLLLHK IEVKCEIENHLLEGYKNEFKQVVLNLINNSKDAIIEHGIEGFIRLYSRIE GEFLALYVEDNGGGIAPEMLNQIFTPHHSTKGEAGTGIGLSLAKKIITEH HQGEISFSNTDQGALFRVALPKSYRLFKE >WS1482 ATP-DEPENDENT RNA HELICASE, DEAD-BOX FAMILY DEAD MDNHVNAHEEQEQAGFEQFGFKENLLRGIHEAGFKVPSPIQVEAIPLVLG GHDLIAQAQTGTGKTAAFGLPIIQNLKNDGSIEALIITPTRELAVQISDE IFKLGRNCRTKTVSVYGGQAIRRQVELLEKAPQVIIATPGRLLDHLRNDR LKNFNPTTIVLDESDEMLDMGFLDDIEEIFTYLPASRQTLLFSATMPAPI KNLAQKILHNPKMVKVTTNETTNSDISQRYYIINEYEREDAIVRLIDSEA PSKTIIFTRMKKEADDLSNRLIAKGYQAGALHGDMEQRERQAAVNAFKQG AIDILVATDVAARGLDISNVSHVFNYHIPLNPESYVHRIGRTGRAGKKGI AITLATPLEFKEIRRISETTKATIELYEIPTIAETLKQTDSKLIQNLLNH SITDDALRIYEQIRGEIDTTQLACKLLSMLMKKSSIMGPNKIGLSKEDLM QLKNRLSGDDRRDRNSRGGKGGSRGGSRNSGGYRRDSRDGNRSSEGNYSR RKRRD >WS0785 BH0401 PROTEIN MKKETKHFRALLADNALYYIYSNISAPLSLQELAKEAGVSAHHFHRIFKE EQGQNLYETIKSIRLQKAANLLLSNHYSTISEVAQLCGYSSSASFIKAFK GRFHLTPREWRHGGHRQYAKEILSTSSAAMASQRSFLGLEPTIKKIPAFR AVYLRHKGYNKSIALSWQKLMAWGFEHQISSQARQIGIHHDNPSITPLAE CRYIAALEVEEGFRAQGLLGVMEFPPTLCAVFEVQGRYGDVLGLIDYVYH EWLPQSGYEAKTIPAFALYQKNHFLDPLGNFQLDFCLPVGVV >WS0376 PUTATIVE TWO-COMPONENT REGULATOR MAECNYLEILSDKKVLCVEDEEVIRSNLMETLELFFDKVSGAKDGFEALE QAMCDTYDVFIFDISIPHLDGLEVLKRVRQFNKKTPIVILSAHKEQEYLW RAVELKITRYLTKPYDKNSLIKALEEVALELMDYHPLFQISPLHSYDFCR KAMTCKGEMVYLSKKREPTS >WS0976 hypothetical protein MISSLQILPYLPLEHSEAEQFLWEQFRLHYGTKVSSQRLMELQERFKKER LDPLYSFFIALEGEEIVGCIALSPYDQRISSLRLRYTEGFVGEIGRCYVK ESLQRQGIGSFLFKQALQRAQEIGYETLYLHTHPFLSGGFDFWKKRGFQA LFKEEGEWQTIHMERGVED >WS1455 hypothetical protein MPKKGASMTQRDMAGYLGVDTKTLYNWRKEKPNLYKTILLGFKFMEAVEE SRKSYEKLKRLGEELGAKSSKP >WS0934 PUTATIVE TWO-COMPONENT REGULATOR MNLEIFKTQSVLYAEDEEGISRHVGAILEIFFKKVYIARDGEEALELFYR HQPDVLVLDVCMPKLDGLMVLAQIREHDRKIPAIMITAHTEQPYLLRAVE LNITKYLQKPFSKESLMESLRACEEYMRGWLGGELRVEIDESLSYNPSNK RLQIQEREIWLTKKESTLLEILLAKRGQVVGFDELINEVWGLEGGSRETL KFVIKEIRRKAGRAFIQNSFAQGYFIPKRS >WS0941 hypothetical protein MLNNNYVPVDDIEEFHRKISCNIKRIRIEKEMSKLEVALSLGFTSVTFYT NAENNKRGKHFNLEHLYKLSKIFEVEVADLLA >WS1798 TWO-COMPONENT RESPONSE REGULATOR MKILLLEDERMLRESLREYLETLGHEVKECEGGEKALALGLSQPFDLFLF DVSTPQKSGFEVAKELSSRRILTPLIFMTARVEIEDISKGFELGCIDYIK KPFHLKELALRLQNLPQKTSAPRLIALGGHYAFDLATATLYEGEHPKNLT PRQREILKLLCENQGKVVDFDLFRERIYTEGFVDNATIRAEVSRLKKLFD EEFIQNIRALGYSIA >WS0847 hypothetical protein MNTYLKNSPGFWIGRIHHKLKNRMNQRLKPYDLTAEQRLILLRLFEFGEM TQQQLCQKTFTEPSNITLTLRRMESHGYVRKKPHPKDKRASLIEATPKAL SIQNELERIGLEITDSLLLEVDPSEKETLLRVLQAMYQKMLQEEAIEEFS F >WS1919 PUTATIVE TRANSCRIPTIONAL REGULATOR MSLKQMECVVAVAKLRSFTKAAAKLKVAQPSLSQSIQAVEKQVGVPLFDR STFPITLTHAGEVYVAKANAIIELYKDLNTQMCDVIGSDKGPLRLGFSQT GYQFIPTALAKFCKRFPCADLRVVQVFSTLKLEKMLSEGDIDIATLVLPL SSPEIDYKIIKENQAFLALPITHPLSQKAIREAQDSPSVSLEELKEERFI LPKSTQRSRPIFDEIFRKAGFEPKIFCETETFDIANAIVASGVGACFTLP QFIKEDKQDKVVLFHVDEPLLARTVVLAYRKDKHLSKMACEFLTIARSL >WS0641 TRANSCRIPTIONAL ACTIVATOR PROTEIN COPR MKILLVEDDLDLSLVLKKALQKELYTIDIAPCLADASHLLTHFRYDLILL DLMLPDGNGITFCQKLRARGEGIPLIILTAKDTIMDRVFGLDSGADDYLA KPFSLAELMARIRARLRNPITPENPLALKIADLEIDQRTKKVTRGGKLIL LTPKEYRLLEFLALNQDATLSEEIIKEALLDFEEQTLSNVISVYIYRLRN KIDKDHSVKLIHTLRGIGYRFGYL >WS2047 PUTATIVE TWO-COMPONENT REGULATOR MMVDNDILDGLKNALILVVEDDNDLRLAIERPLKRRCKALYSASSGKEGL KLFREKRPHIVITDINLPELSGLDMAKEIRALSSEVAIIIITAFGNEENL IRSYNIGACSLLKKPIDLDELFMILLSNAKKTLDKGFIEINEEFSYNPEN QTLYHQGKSVELTKKETKILDLLIKNKGNPVPYDEFQSRIWGATPMTLDA LRMHINSIRKKSFQEIVKNFSGVGYRFCRTLSD >WS1608 HYPOTHETICAL PROTEIN-AraC-type DNA-binding domain-containing MSYRLNIENLREFMSETSDSCEHLVFPQKRGIYRAQKEWIASGITLFKCT LRAEDEVVIEQKESAFFGGAFIHVVLEGGVSFETSQPKGSFEYRRGYTTA MEALHPSGITRVARGVSVHSIGIHIHEDFLRSREIEWKKIAKEPRLLPSN PKVEWIAKSLYQGRGGAQSDADRLRVESQILEILSCELQREETRGGMERV KLSGYDLEALHKARVILEQNLKNPPSLIELSRAIHLNEFKLKFGFKRLFG VAPYEMLFLFRMQRARGLLEEGIFSVGEVAKEVGYAQQSSFSAAFFRHFG VLPKEVAKSWKD >WS1168 conserved hypothetical protein MEKIVPKCEGGAECVTEKALNIIGGKWSFLIIKNLAGGKMRFGEIRKSLH DISPKTLTVKLKELEEHEILTRTLYPTIPPSVEYALTPKGEEMIEIIEAI KKWGEKWT >WS0905 hypothetical protein MPAVVDREEKAREICQRAYEVFTTEGIEKFSLNQFIALLGISKGQFYHYF KTKEELIFAAISEKSEWFVKEIKENLKGAKTLIEKLRILFVFYVGEEEEM VRFRRILFDTFHLYIYSKDLKAREFNAETYEWMDRELEAILKEEIARGHL REEVLEWVEIIPSSVDGIYLRSIMTDGYDLKKALEDLFIKIEKIFGVEGE RGRGLDVR >WS0114 PUTATIVE TRANSCRIPTIONAL REGULATOR MRQKVSSAAINFILGHLTRNQRLFPSSELSPEILDQLRDAKASVDIASYK NIFLRVVKITGNQNLGLYIGENIRPNALGILGYILENSPTISVALENLLR YHTLLSRSFFVQKSEGGRYVKISLSTTPPEKPPMDRYSNEVNLSAFVAIL NDLTKETIRPEVVKFTHRRPENIEAYYPIFGQNLEFEAPNNLIYFSKEIL GYPVCCPNIAMLEFFKMQADRILDEEEESYSIRVTRILSEMIHYKAPEVK DVAKRLEITPRTLQNRLKVEGTTFQELIISTKKQLACHYLKTKEINIQEV AERLGYSETSAFNRAFKQWTNFTPREFRKNRGS >WS0077 PUTATIVE TWO-COMPONENT REGULATOR MAVRILVVEDDPLLGEMMEEFLSEQEFEITLASNAKEALDLAYERPFDLW ILDVKLPGGDGFSLLKSLREAGKTTPAIYTTSLHTLQDLESGYESGCDDY LKKPFELKELLVRIKALLKRRFAHKQEEFEELGGGWRFCLGSKRLYQGED LYSLASKEIELLSLFLQNKNRLLSHEEIFDRLWSYGESPSEMSLRAYVKN LRKILGKERILNQRGEGYLYVG >WS1224 PUTATIVE TRANSCRIPTIONAL REGULATOR MSSPSRRDEILNTALKLFNEQGSANVSTRHIAEAMGISPGNLYYYFPHKE AIIHAILDRAEALFEEVYDFDSAHLPSPKSLLKRREHYFWEYRFFQSEMM LLFQNDPSLKERFGKLQQKRLKEIEKMLGVLQEAGILRPLKEELKKILTQ NLWIVSNFWNLFLEIEGRLFEEETKGVIENILALLKPHMTREGIAWILLD NEHEGVKA >WS0803 conserved hypothetical protein MLLCDIGNTYLHFYQEGKVWKELPRRLKAGMEVQEVYYISVNPPSARRLL EVYPHAIDLAPHMVLDTAYKGLGVDRMAACKGIEDGVVVDAGSAITVDVM QNQVHLGGFIMPGIASFSSMLKSISPALEKELNLSVELSALPQNTRDALS YGAIKAIVMMIQNSCKNKRLFFTGGDGKYLARFFENAIHDNSIVFKGMLK TLEEMKEGKR >WS2088 PUTATIVE TWO-COMPONENT REGULATOR MTYMEEAVDLSVLYVEDDELSRSGIFNALKRKVKNIHFAANGQEGLEVFK EHRPDVVITDIKMPLLNGLEMAKQILEMEPSVEIIVATAFEDAELFKRAI DLDVDKYLTKPLDVTQILMHLKRIEMQKRLEREFEVYSRALNEVASIFWF DLELECLKVNPRAIASGGEHGVENEKLKEMARLALEKGGRHQEGNKIFSV AFNVAKEPKGFCLCVMESME >WS1088 hypothetical protein MKKAAFTPTPDWLRTWVEDKDRRYWSAQKHARGILSYTVALKSLEDYFKA IKLGSLKPNQRSIAYFAKAWGWNWTKTLRFFVIVMEALENLDARFQRLKR KAEEYAQRAKEYVYKARGKIFNSSTKGDESEIEKLFLDAMAGVAKNNPAF YRRKIKENLRAGDPATVENFENFKHARTAEEQKRERDALQEKIQNQIEIY NMKNDEKIIKCIIDSEQKKVQLTRADGQVLILELSNLDLLGVL >WS1875 RIBONUCLEASE MREFLTTLALGIKTKDIPRSFLALVETLREKGALQAKGERIFLDLAFRVG VLDISREGVGFLESFGSSGKDLLIQKSDLKGAFKGDVVLARRVYSHKGGR PSAKVVEVLEKKNAILVAYLDQHAGRIEALDIKNGLSLPLNASAKSLKAL PPQTVIRLDVREGRIIEVLGVLSDPRVDEKISLALFNKSEPFPRECEEQA ESFGRKVEASMYPARQDFRSLPFCTIDPIDAKDHDDAVYFDAKESILYVA IADVSEYVTPHSPIDKEARVRGFTIYLPHKSIPMLPRNLSENICSLKPQE DRLAYVWKIRLHKRTALPLKAELHEAIIRSKQKLSYEEVDEFLEEPKANS TILKELQEPLLNLYARTKKLRAKRLERGYEFFNEENRLLMDENLNLISIV SEKETPSHSLIEECMLLANIYSAKHLEKGIFRVHEEPKLEKIEELLWDLR SLGLEAKPKETLHATIATIQKEAEAKGIRTEVDRMIIRSQAQARYSHQKI GHFGLGFEEYSHFTSPIRRYSDLVLHRLLKAELKGEKRKMEFYLDALAPL CDSLSALERESARVEMDYKDRKYARLALERLGEVVEAVVVDEESPPLARA EGFLKGARIVLGKGLVERLSRVRVRLMDVDVASAKIYGKVVGIIKEKRVQ TGV >WS1339 hypothetical protein MKMEREVALKILIVEDDTDAREWLSTIISNHFPEVWSAGDGEEGERLFGL HAPDVIITDIRMPKLGGLEMLDRIKAGGAKPYVIVISAFSEMKYFIKAIE LGVHLFLPKPIEPGRLMETLEDFRHIKLAKLKKEEAEQERIRSLLFESKK ELIRLIAHHWRQPLNVISITAENIKLNLDERGIEGHEDTHHLADKIVTES LRLSRVISRFSDTFFAKEEVGRHFGLHTVLKDAFEIAEPLAQEARCLLEI EGNDEVIFGLKGMLVQILLEVFKAIMALCDQVNRGELLVRVVCESFEGEV KIWMADVACAGRCWSEVMFEPFAGGFEEKRRDMELFVAQHLLRRYFDGMI KIVDRGEIRGLEITLSRNPKKFNSPLA >WS0673 hypothetical protein MDNIIRFSVSLPENLLAELDNKIVSQGYSSRSELVRDLIREKMVEEKWEG GR >WS1817 RESPONSE REGULATOR OMPR MVCYCKAKPQPQPIPSYENDRQTPPFVEERLMLEILMIEDDLELASILSE YLKEHDMNVTSFDEPYTGMSAIGTKHFDLLLLDLTLPNLDGLEVCKRVAK QKKIPIIISSARSDINDKVNGLEYGADDYIPKPYDPKELVARIHSVLRRY TPDKETNPSSEKSSSRSPFRLEGESREIYFKEALLDLTRGEYEILSYLIQ KKGAVVSREEIAIHSPSINPDSSNKSIDVIIGRLRAKIEDNPKNPTYILS VRGVGYKLDHD >WS1959 hypothetical protein MKTLPWRPKKILLFGFSPCDKGRLWLSLIHQGYLLLDAFSLSEAKSLYYQ EGFDGVIADCSLIPKEESLLLELHVLFGVRVILLLSPQGFKKQERLLLGG AIACILKEERSAWMRELLGFLAHLKSSTPREILLLSPSTFLAKRVREALL PRGYHLHTEKRSEEALAVASQGGLRVLILDSGVEEENPQELLWDIKETHS SPLPCLILSSHLDRSQVERRFGSSGYERLVEPYGYGEMIKKIEEMSKD >WS0288 AraC-type DNA-binding proteins MKPPIKIDYRASIDITKKITHPFSREVYMGKMKEELGEGSGIWYDMGHGI ALAVREFVPRQEMVIFEQSDVAGAVFIFNLGSDLRFVFKDQKEHLLKKNR FLVGLASTQFYVETPFSSGQVWSTLTTAMKQELFLELATPIKNIQEHLKE ASKHSYSIFQDRSIDPKQLELLRYLQKRDSYEETLESIHLESKATELIHY TIERMARALDDSSLSALEEGWLSSLERAREIILQDYHNPHLSIKEIAYRS AINECYLKRDFKKHYGMTILEMIQKRRLEVAKELLHERLTLKEVAQEVGY RHVGHFSKLFSERFGITPSDYKKELRNF >WS0362 hypothetical protein MANSLYLPALLSDEQLGALLKEAEKIKENPDTEIPLLMQAITDLALNAGK RALEHQEIAEALETYLRYLSLEKLHRLGIIKEYEQPSPKEFFLPAKEITL TLLTPPSA >WS1523 RESPONSE REGULATOR OMPR-CheY-like and winged-helix DNA-binding domain METIAKNPSIRAALIEDDRQMCEILTEYLKAYAIETHYFRLPDEGIRAID QGGFDIVILDINLPQMEGLEVCQILKERHKIPIIIISARGSVSDRVLGLE LGADDYLPKPFDPRELVARIRAALRKESGSTPLALGSKRSFGVFALDEEA LEIDKGGEAIPFTKGEYEVFALLLKHEGKALTRDFIVDNTEALRWESVGK SVDTIIGRIRVKIGDDPKNPRYIKSVRGVGYRFGR >WS0496 hypothetical protein MTPKKSLLLDEIIREYLKQQEPIGSESLRLSLNIKISSATIRNHFKTLVE EGALAQPHVSSGRIPTELALKNYWRKKLLPLEMLEFESLKKIEQSARETG IFCALRFYKPNFLQEVVSVGTRFLVLGFEEGEAVVKYSGAMERFLGELVG LEIRDIRKIAYQVCAHELATKLDHLLEGEPVLTFGLKELAELLQPSREGE RLFHDISKGKWLDTLEEGLYFDRFIPRGALAFIQQIRVEKSAAKLMFMGS LNRNYEAFYQEALA >WS0671 hypothetical protein MLTIVYDHHQRELNQKMIDIQHNSHIHILCNTHVHINHHNCLETIILKGI PKEIEEIALSIGGLKGVKFSKLTRASSF >WS1434 PUTATIVE TWO-COMPONENT REGULATOR MEAWQESLKNLTLLYVEDEEGIRRPMVDTLSYYLKEVYEAEDGEAGLECY YTHRPDIIFTDLKMPHRDGLWMVREIRKHDKHTPIAMITAHSDKEYLLSA VELKMEKYLIKPIALEELLHVLRLCIEDIEEERGIVLECGSVRFDLKNRL FIKEERETPLTQKESDFLALLLRKKGQLIPYEEIESQVWRGEFMSTDALR TLVKNLRKKLGIPCIKNHSLAGYSFEG >WS0854 PUTATIVE DIAMINOBUTYRIC ACID ACETYLTRANSFERASE , MFRPPSIKDAKKIWELIGRCKPLDINSPYCYALIGRDFFDSSIVYEEEGR IKGVVIGYLRPRAPERLFVWQVAIEAKSRGKGIAKRAIEAILKNLERKGH CIQAIEATYTPSNLASKALFHALGREWKVVWIEENFLEGALLSAQEAHEE EWLITLPFSSEALGVQGANHANL >WS1726 SIGNAL TRANSDUCTION RESPONSE REGULATOR MKLLIVDDILDNIKVAMNHLKPLGCEFIYATSGKQALERALIHHPDLILM DVMMPEMDGYETVIRLKQSAETASIPVIYLTAKIDPKDIARGFECGGVDY VTKPFSGAELLARVRTHLELRRYQNHLERLVSERTQEVEKLRNAVIEALG GMAEYRDPETGGHIKRTQHYVRELAQRLYEKGKFLMILNPEYIQTLFLSA PLHDIGKVGIRDHILLKPASLTPEEFEEMKRHTLIGEQAIAKLIHNAGEC EFLSCALEIAGSHHERFDGSGYPRGLAGEAIPLSARIMALADVYDALVNK RVYKEAWSHERAMQVMRAGRGNHFDPQVFDTFLELEERFIEIYETFRDD >WS1463 PUTATIVE TWO-COMPONENT REGULATOR MRRIFILEDDPLLGEILEEHLQKRFEVTLLQEGLAAEECLLKERFDLWLL DIQVPGLNGLELLKNLRTLGFKTPAIFITSQNSSKDLKAGFEAGAHDYIR KPFDLDELDARIQNLSNLFGLGEEEEVAPGITFLANRNLLILQGKSFSLR KKEAEIFSLFLQNRGKTLTPAEIIANIWRYEETPTPSTLRSHIKSLRKLL GDELIQNIRGLGYRFG >WS0665 hypothetical protein MFEISHATPGDSKEAVGLLREAMGEIAMTLTQESDEERILSALEEYFKNP STRIGYPRVWLYREKDEILGAINLYLGDEAKRLDEAILESIRNRGKHLEA LEVECEEGDLYIDSIAVSPKARGRGIAKKLIEHAYGEARRLGASQLSLVV DCDKIEVKEYYARLGFVTEGEKWLGGHLYYRMKKPLV >WS1120 PUTATIVE TRANSCRIPTIONAL REGULATOR MGEDRCDCNTVHFGIVAEVRRKMPLEEQLYDLAELFKVFGDTTRVKILSA LFESELCVCDIADLLGMTQSAISHQLRVLRQARLVKPRKEGKVVFYSLDD EHIKNIFDQGMEHILERQGGEYGEA >WS0766 hypothetical protein MEKTKIQPKDYLRAISALNDETRVLILRFLQEYGESCVCDLELSLGMLQS RLSRHLKILMEAGYLEKERKGVWSHYYIAPQDWFREKALENIKMVDVKIP PQQKACPS >WS1423 PUTATIVE RNA POLYMERASE SIGMA FACTOR MLEAYYRELLGYFQKSLGDIHLASDVVQEAYARVLSLQAKEIPIAKPRAL LYKTAKNIAVDEYRRNRRQENLLHEQARACVQEWQGEESFELQETLLRAI DSLPPRCKEAFVLHKLEGFSQAEVAEKMGISKNMVEKHIIKALLECERAL EEAEKKR >WS0751 hypothetical protein MRKEREGFGMDELLKIGFATSDETRLRILAFLVREGECCVCELEASLGIF QSRISRHLKILKEAGFLEVKREGKWAYYALASQAPLQALFIEQISKLSLP LPPKISACEIKGEES >WS0589 hypothetical protein MTNYYEELLLYVRGKVSSKDHAQDIVQESYTRAIAMQAKQEINNQRALLY KIAKNLIIDKLRSSRVVSEVAYEETLLAPSALEPEEAAMEQSREAILKRE LKKMPPKRQEVFVLHILEGYSRQEVARMLGISSDAVDKHLSRAIMELKEK LNPKKDRS >WS0858 hypothetical protein MSAVAEILKTKPRTMRMYEERGLLPGGHEKEKKLYSLEEIDRIMLVHYLA THERINANGIRFILKLLDWGITQEAKEALFKEAQELIEKESMAEIKEGDL >WS2201 TRANSCRIPTIONAL REGULATOR (PHOB-LIKE) MSSLLLLEDDALLGETVKEFLEEEGFRVEWALDRAGFERFTGERSFDLYL MDVKLPDGSAFELLKHLKSEFDATPAIFITSLSDGESLREGFLSGCDDYL TKPFNLEELLWRIQAILRRSKGDFAGVKIDAKRLFFPKESRLIIEGEEIV LPLKESKLLELLVESRGRVVGKEEIYDHLWPEEEPSGGALRVYVNALKKY LGEGSINNIRGVGYRFEL >WS0033 conserved hypothetical protein MELLWANLEEEAHERACVKLLNDYILDPMGGGEPLEKEQALKLIEGLRKT PNVEILLASMEGEFVGLCTLFVNFSTFKQKPYFNLHDVIVSPEARGKGVG RSMLEHLIKEAKRRDYAKVTLEVREDNQGAQTLYQSLGFRESEPRMFFWS RML >WS1918 hypothetical protein MKGIITAIDDLKQEALIKVERSSAPFAFGFERFEGARDDLFVGLEVEVVL SAKKEIAKVIPDKNAKKPENLKYLELTKSVEDCVVSYFNDIRELLSRYKS IDDSAPQIDFLRIRRFLFTAYNDLYDLDNSVYNPKLEHLRIELGKIQKEF ELFRKKTGYPIKYSYDKVFLRQQGNYLKLEEKIEATQGFIRSATLKERPL ADRLKEKEKKLLAIEDKKSQAYFDFEKEVKELRKRYVDLLHFISLQRDLL AELSALSKMFVERYFQEFVDLYQPLSMELERKLLWLLNTKAYELDSNLWD RAKQSKLIRQFFMDSGITGTYSSKTFLKYYLRSLDKDKLRNENKELFSLL AYLESISKKSIFVIRHRFEAAVRCKYLLENFDKELQVSIIKDPLDALKVN DSVRPDIILLDMELAGINPFELAQKYRQMFDAEGKSTLFCLFVNDLTSDL FTHAKKVGIKHFLRNQATDDEFIDSMRTIL >WS0239 hypothetical protein MQRMEEIAFKALNRVNNDRYLLANILFARIDELSKGAKPLVNMDVKKHKL TDIAMTEVAEGKIALSQIDQL >WS0998 hypothetical protein MTLKECNLIVLDKPRALSSEQEVYLVDQFGLFFVHHSFESLLSGFKSHPM DMILLVLEALGGSESLSALKAVKGMYPEIPILLATDIAPDEIDKSIPFAL AGMLPVAWQGDRFSEVLRSQESSILRYAKKERERRGDAPQELGLEESIAR FFSHTKEKLAAFDLEAESGKRFNYPLMKRFIHTAYNNFIEVDPKIRSIRK LTEAKDRLSEALRLQILLKKRIDVSIEYNYEEVYLKNQPAYIDVIQKLEQ TLHKMGVYRKEMGILTSQMERFKEEMKHASDPSLKVEAEQSFKNANRRYV DRMHEIKQMQESLGVMEATKEELWKRDFEAFMRVFKEEAGKYEREYEELV DALAYRFDRFLWIAARESRLVREYFEKGMIEGVFSSKTYLEYYVKHLDKN LSSKANRELIRYRHKMEEENAIHVALVGNVTEDLLQDKRRLEATDGYIRV SLYVPQTLENFFEEAKEGKYEIVMMEDVVGRWLFFQLWKRLKESLVDSSF LPKQVLLVRHYKDPERIREKALSMRWENILTPPITREKLKALLLSIA >WS0306 TWO-COMPONENT REGULATOR MRILIIEDEITLNKTLAEGLNEFNYQTDVAENLKDGEYYISIRNYDLVLT DWMLPDGSGLDIISQVKSKSPRTAVVILSARDDKESEIEALRGGADDFIA KPFDFDVLVARIEARLRFGGTNLIEIEDLIINPDEEKITYKGQEIELKGK PFEVLTHLARHRDQIVSKEQLLDAIWEEPELVTPNVIEVAINQIRQKMDK PLNISTIETVRRRGYRFCYPKGV >WS0663 hypothetical protein MKETIGQRFKTAIEKKYGKFENKVIAQKYGMSEQAVIKFKRDDNLTKSMI EIANQEGINLNYLSNGIGEVFLDTTQECAKERVIGENDFKEILGEILSLD LHSKEYMYHKIKSELLSFKRR >WS0777 hypothetical protein MGETRGVLETIRYRAIIEGMKNPERARAMVQMRAFQELSMQEAFSKYVFE RIKTRNSSRLITFHGRYILIHGANLEDSLFVYPLWKSVNEPLEQLSSEIR AAVGDIAKGEKSNIYITYPKTRHLAKHITIKSTALEKMKKSYCLKLVPYA CDLGRLLNMNKGEARQ >WS0950 SENSORY TRANSDUCTION REGULATOR MVKPLIAIIEDEEDLLELLEFHLKKADFEVEGFLNVQNIEKLLKEEPIDL LLVDRNLPGVEGAEFIKRLREKGYATPVIFLTAKSGDKEKLEGFEAGADD YITKPFKFEELIARIRAVLKRTKGEEQEVYQYRDLILKPKSRELFVDSES VELTKLEFYLLLEFIKNRHIVLSREYLLETVWGACGEYQDKTVNVAIKRL REKIDPDKEKNYFRSVRGEGYTLC >WS1033 hypothetical protein MKEYEVLKNARILYVEDEEDVLKFTSMVLEDYTGELYIAKNGEEALEILA HQKIDLLITDILMPRVSGIELIKEMRQRYGRSISTIITTAHAETHYLLEA IDLGVDGYVLKPIDVEDLLRVMEKALLPKMQAHELASKNLLINAISVFVG GKKIEIIKYLLDNCDQDNVFHGSYEDIIAALNVSKPTVVKTFKQLMDTGL LTRIKNKIYRLHPDISGSRALVEVEEEEEEA >WS1254 PUTATIVE TRANSCRIPTIONAL REGULATOR MYSYDEPVYLISVVAKILNIHPQTLRQYEREGLIEPGRTDGKMRLYSQRD IDKIKTILRLTRDLGVNLAGVDIVLRLKERLDEMDNELEELRQNLEKIRC QEDGISKGSIVTKRSSYEIIVFKED >WS1167 CAC2934, PREDICTED TRANSCRIPTIONAL REGULATOR MYKIENEAFVCPMEVTLHILNDKWKMFIVYALLDGPRRFKDICEKFPKIT QKTISQKLKELEAAHMVNRVVYPQVPPKVEYSLSETGKRIEPMVKAMFDF GVFYAETYGCVE >WS1639 FLIA, RNA POLYMERASE SIGMA FACTOR MMSPKEGQGYSQHLKYSQDELAVSYLPAVKAMAYRLKERLPSSIDTADLV SIGAEELIKLSRRYNEALNDSFWGFAKTRVQGAMLDYLRSLDVVSRGNRK LIKQIDVEISHYMNEHSSEPSDEYLAEVLGEDIKKIREAKIASDIYVLMP IEDQLSALHEEATEGRIEQEELVGIISEILESLSEREQLIIQLYYFEELN LKEISEVLEITESRISQIHKEVIKKIRERLGGAHG >WS0799 GREA, TRANSCRIPTION ELONGATION FACTOR GREA TRANSCRIPT CLEAVAGE FACTORGREA MQKEPMTIYGYEKLQRELKELKEVERPQIVKEIDIARGHGDLKENAEYHA AKERQLFIEARINELSEILSRTQVVDPATITHEKISFGSTFKVMDLDTEF VYEYTIVGAPESNPDRGFISFYSPLARQLIGKVPGDEINAKLPNGEIDYE VLEVYYKEISFE >WS0791 HYPB, HYDROGENASE PROTEIN B MQNRRNLNNPNLQTKSLEVVERILSKNDLEAQKLRERFAEAGVYALNLMS SPGSGKTTLLEQMALLGGVTFSVIEGDLETNRDADRLRAKGVEAYQITTG EACHLEALMVAKALDQIPWQKKDFLIIENVGNLVCPASYDLGCAMNIVLL SVPEGDDKILKYPTMFLCADAVLITKSDMIDYFGFRLSQVREDLNRLGKA IPIFETSSKEPSTIQKFIQFIQEKKEQGYVSSHTF >WS0691 LIN, LIN1550 PROTEIN MTGISTKGIYGLGALYYLTLNLHKPSIQISEISQNTNIPQNYLEQILANL KKAGFLKSIRGPKGGYALAMPPEQIIVYDILEALEGGLCAIECRTDIEAL KLFWEDAGSKVRQIFSLSLKDLLRYEEMIQRGNMYFI >WS0874 LYSR1, TRANSCRIPTIONAL REGULATOR (LYSR FAMILY) MLKDFAKLETFLIVVRERSFSKASAKLGISQPAVTQQIKYIEEYLDTKII ERKKNGVKLTKDGEKLLTIALRLERAIVTAEKETMKIIKKDFSFNIGASF TIGNYILPNCLGNIKEMIKNDVFVKIDSSDNIIEALIEKKIDLALIESPI FKDNIVYREWVEDEFVLFSNSPLPKTVKKEDLLTFSWICREWGSNTRRII NETLDDVGIDCTTFDIKGVVSSSTGVKHTVLKSPKFPEESPKPTVAILSK YVVQDDLVNNSLHESKIRGCKLKRKLYLAYLKDRKNDAFVDTVSSCLMCN KNLG >WS1239 MFD, TRANSCRIPTION-REPAIR COUPLING FACTOR MIQSSLYHALKNPFPYQILITQDDKESYLASEVARFRGFETILFPDFRAQ KGDDLRSYKEELLALLGALRKWYRAPKERLLLIAPLRSLLHPLPKEELLQ SFHLGFGDNLDIGELKERFYRFGYEFVEIIELPGEVSFRGDIIDVFPPQE SSPVRLSLFDTQIESLRYFDLETQMCEREELDRIEITPALFALDEATQKE LEELVSASSYGAFSKDLMSLGLWYLKDKGEVLPRRVPSILTAGAKEELLE LLELQESDELRFLEGLNLLATPLEHSDIIISPANFLSFLSLHANKEITII ARNEALFRAFDLKEIPCKKQIGDFCVNLLTPKEVILSLNQNTKKSAKKRR PTFAIDELRVGDYVVHKDYGIGIFKGIIQERVLGALRDFILLAYQGEDRL LLPVENLDYIDRYVADSGSIPSVDRLGKGSFAKLKEKIRTKLLEIASEIV ALAAKRELIEGRAIRTDFPEIEIFQHSSGFVYTSDQEKSIREIFSDLEGG KVMDRLLSGDVGFGKTEVAMNAILATVMSGYQAALVAPTTLLAHQHFQSL KKRFEGRGIKMARLDRFLSSKERTSLLNALKEGEVDVVVGTHAILSAVFK RLALIIVDEEHKFGVKQKERIKAIAQDVHMLSMSATPIPRTLNMALSSIK GMSTLLTPPSEKLPVRTFVKEYQEALLKEIVHREIRRGGQIFYIHNNIAT IERRQKELLELMPNLKIAILHSQIPEKETEEIMLAFEEGRYHLLLSTSII ESGIHLPNANTIIIDSSDRFGIADLHQLRGRVGRGSKEGFCYFLVEEKES LTPEAKKRLLALESNSFLGSGSVLAYHDLEIRGGGNLLGEAQSGHIKGIG YALYLKMLEEAIHSLSSKALPKREDVDLKLSINAFLSPELIESDRLRLEL YRRLSRCESTQEVNEIEVEIHDRFGSPDLYTKQFLELILIKVLASLQGIK TITNYNQNITFFYRDETKKSFSAKSRDDDDLLAAILEQLQGKSA >WS1404 NIFA, TRANSCRIPTIONAL REGULATOR (NIFA FAMILY) MDNSCHTPSNRCTRYQELRALYDISLALGGSVGEVKKAFEEALGLLKRHF FLDKSVYYELSEESQTLNVFASAGLSKEQEFLASYKVGEGATGLAAKARE PIIVENIHQNLLFLNKSGSRNEGEISYLAVPALSQERILGVLGVSLTKHS MSDFDEMVTILTIAASLMAQARRIHQSIHEEKKRISEEKLYYKEELLKQS EIIGYSPPIKRVSEIIAKIAPSSATVLIRGETGTGKELIAKAIHNYSPRK EKPYIKLNCAAIPENLLESELFGHEKGAFTDARETRKGRFELADGGTLFL DEVGDLSLPLQAKILRILQEQEFERVGGSKTIKVDVRIVAATNRDLEEMV RMGDFREDLFYRLNVIPIFSPPLRDRGDDVILLSRYFLERFCKRHAKELH LTPKAEELLKHYDWPGNIRELENSIERLVLLAPSESIDEEVVLSVLPGRV HGYTKEVKTRADLEELERSAIIKALKECHGIKLQAAKKLGITNRQIGYKI QKYEIEPEDYLS >WS1778 NUSA, TRANSCRIPTION ELONGATION FACTOR MEKILDIIELIAYEKGLKIDSVAGAVKEAIIITAKKSLDEHIAYDVEIDK KNKTLKLYQKILVCPPGDERLSSDPDNHISITEAKEMDEEVEVGDELRYE LSLENMSRSAVNTLYKELEFHIQRLIETQLFEKYKSQVGKIVSGSVVRVD DEGNTFVEIDEIRAFLPKKNRIKGESFKVGNVVGAILKHVSIDRKNGIQI ELSRTTPKLLEELLRLEVPEIKDGDVTIEKCARIPGERAKVAISSSSPKI DAVGATVGVKGVRINAVGKELKNENIDCIEYSPIPEMFVARSLSPALISS VKIDGTKAIVTLPSEQKPKAIGKNGINIRLASMLTGYEIELIEQGGVLGI PTASLTQTPKEEKKDISSLASLFKE >WS0296 NUSB, TRANSCRIPTION TERMINATION PROTEIN MATRAQAREAVVSLLYAYDMGNTEIRKFAIELLEEKRIKNRQQEFALELF DGTIAHLGEIDEEIKKHLKEWDFSRIGDMERAILRLGTFEIVYSGVDRAV IINEAVELSKTFGNDNSPRFVNGVLDALRPDLKKG >WS0462 NUSG, TRANSCRIPTION ANTITERMINATION PROTEIN NUSG MSFDWYAIQTYSGSEQSVKRAIENLIRENKIEDRLEQIVVPTEDIIEVKN NKKKITERSLYPGYVFIKVSLDTELWHLIQSLPRVGRFIGEAKKPTPLSE ADINTILEKVKNRAAPKPKVSFEAGEVVRITEGPFANFTGTVEEYDMEHR KLKLNVSIFGRSTPIEILYSQVEKIV >WS0353 RECG, ATP-DEPENDENT DNA HELICASE EC 3.6.1. MEPSDLLKLSKLHCKDALDFALLAPKGYEDRRPSSELVSGAEGVVEIETL EFSLQKGRARGLAWLERFKERAELIIFHPSKYHHALFAPKERFFVKAKVE RRFGKLILIQPQKLAKIGEILPKFSTKVFKNQTLIELASRVLSKESLIAL GIPALYASRLCELFFPDDSFLRRYQQERGIPKEHQEALKFAEIFRHLRAL VGKKRSFEALCRCQNAPWPFVDSLPFPLTSGQKEAIGAIWRDLSSSKAAR RIIMGDVGCGKTLVILAAAYMAYPKQAVLMAPTTILAEQLYAEAKRFLPA HFKIALVMQERSSDSLEANLLIGTHALLYRKLDQAALVMIDEQHRFGTAQ RSTLERSLSDERGHRPHVLQFSATPIPRTLAMIESNLIDFTFIRDIPFPK DITTRVIAKGDFPALLSHLAQEIAQGKQAAIIYPLVEESENLDYLSLKEG EAFWRKRFEGVYVTHGKDREKEAVLEEFREKGKILLATTVVEVGISLPKL STIVIVGAERLGLATLHQLRGRVSRNGLKGYCFLYTHHKASKRLDDFAST LDGFEIAELDLKYRQGGDLVGGGRQSGESFTYFDPSCDQELLQEAQAILN AQVKR >WS0810 RHO, TRANSCRIPTION TERMINATION FACTOR MNDCNGQNKSAKESTPATPSNGQYPNKSRTHIPVEGYKIEDLRAKPLNKI MEIAETLGVENPQEYKRQDLLFEILKSQVNKGGFILFTGILEITGEGYGF LRAMDENFSDSQNDAYVSNTQIRKFALRNGDIVTGQVRPPKDQERYYALL KIEAINYQSSEEMKNRPLFDNLTPLFPTDQLKLEYASSKVTGRMLDLFSP IGKGQRALIVAPPRSGKTELMKELAHGIAKNHPEVELIVLLVDERPEEVT DMERCVKGEVYSSTFDMPAHNHIRVAELVIEKAKRSVEMGRDVVILLDSI TRLARAYNTATPSSGKVLSGGVDANALHKPKRFFGAARNIEQGGSLTIIA TALIETGSRMDEVIFEEFKGTGNSEIVLARHIAERRIYPAMDILKSGTRK EELLLGQDKLIKVWALRNVMQQMNNEVEALTFLYSKMQKTKDNEEFLSIM NEG >WS0055 RHPR, PUTATIVE TWO-COMPONENT REGULATOR MRILLLEDDPEQNRILKEFLTQKQFVVDSYLDGKSVLENLDRPWELYILD LNVPFVNGLELLEEIRRIDRKTPAIIISSENDIDTVLKSFERGCNDFLRK PFDPRELLARIASHTQNRPSCFLIDKRYRFDLGAKLLFCEEDIVPLTKKE LRLLEILALHEGRVASLEEITNHVWGYYQEVDGTSLRGLVSRLRKKLPAG VIKNHTDVGYQLEGRVERP >WS0119 RHPR, RESPONSE TWO-COMPONENT REGULATOR MKIFLLEDNPKLREAIEETLSENGYRVDSFEDGQEALEHLDGSHLLYILD IHVPRIDGLELLALIQGRFIKAPVIIISSFVDLDVIRQAYRHGCADFLKK PFFLDELLFKTHRLCGKLHPLIPLGEETFLDLENALILREGQSLLLSPKE KRLLELLVRARGLLVSFEEIEEYVWEEGEVPRENIRSMIRQLRLKIPASS IQTHKGIGYRLIVDLSSAPTAID >WS0657 RHPR, TWO COMPONENT RESPONSE REGULATOR MMKILILEDNERLSNLMAEALRDEGYKVDLYSDGEACLEVLHQGYDCFIL DINVPSLDGLSVLECIRLHHRQIPTLIISANHDLEKIQSAYRLGCDDYLK KPFYIYELVQKVKRFCLVQSQGIDFGESHRFYFDCSRLFKEQEEIPLTPK EVAFLKLFARDLKRIVSYEELEEYVWEGKESNLNNIRALIKRLRKKLPED SITMITNVGYGLGDRAKRF >WS1208 RHPR, RESPONSE REGULATOR OF TWO-COMPONENT SYSTEM MKILLLEDEPGISMAIERYLKKQGFEVRAFSKIMEALEAIDENRDFNLFI VDVMLPDGNGIAFLETIKTLFFAPKIIMISADSRIQTIEKAFLGGCEDYL KKPFDIQELGLKVNKIFGRLTQEISLKEGIVYERVKRALYIQGEECHLSR KEMMLLDILIQNLGRVVTKEALEDGIWEGNMPSDDALRTTIKRLRQKIGE GIIRNVAGVGYQISLD >WS1899 RNC, RIBONUCLEASE III MESIEEFEKRLGYRFQNKNLLIEALTHKSYKKPYNNERLEFLGDAVLDLV IGEFLFLKFPKADEGELSKMRASLVNEKGFAKLAERVSLGRHIFISNAEE NNKGREKPSLLSNAFEATMGAIYLETGLSVVREVVHRLLDEVYPKIDLGS LFRDYKTALQELTQAKFGETPEYVILGSSGPDHKKEFEVAVCVLGSEYAR ACGSSKKEAQQEAARIALEIFHRKEKEAKESALKGKSE >WS1692 RPOA, RNA POLYMERASE ALPHA SUBUNIT MKNIKTSPYIPTDISIQEIGKNKIKISAYPFESGYAITLAHPLRRLLLGS SVGFAPTALKIEGAAHEFDSVRGIMEDVALFIVNLKSIRFKMRGDAERVT LDYSFKGPATIKGSDLVNDYVDVVTPNQHLATINEDATLTFSLIVQKGIG YVPSEETRNLIPEGYIPLDAYFTPVKKATYEIENVLVEDNPTYEKIVLEI ETDGLIEPIAAFKDALGVMQKQMSVFNSEWSVSSAESTSSDEEDPELKPL LQKIEALNLSARSFNCLDRAGMKFVGELVLLGENELKEVKNLGKKSFDEI KDKLEEIGYPVGSDLAEEVSSALQKRLNKLK >WS0467 RPOB, DNA-DIRECTED RNA POLYMERASE, BETA SUBUNIT RPOB MPTTLKSGNRLRVDFTKIPQNIAIPNLLQLQRNSYDSFLMPIENGESGIE KVFRSIFPIHDAQNRITLEYAGCEYGKPRYTVREAMERGLTYSVPLKVKI RLVLWEKDEKTGEKLGVKDIKEQSIFVREIPLMTDRTSFIINGVERVVVN QLHRSPGVIFKEEESATSSNKLIYTGQIIPDRGSWLYFEYDAKDTLYVRI NKRRKVPVTILFRALGYSKQDVIKTFYPLMKVKAEAGKYLMPFNPEEFIG RIEFDIRDTSGNLIIGAGKRLTQKRAKTLKEQGLEWVEYPVEILLDRHLA EPIVDKESGEVILDTLVQLDEGKLKKIHELGIKEFTIANDLAQGVDASII HSFVADNESLKLLKQTEKIDDDNDLAAIRIYKVMRPGEPVTKDAAKSFVQ QLFFDPERYDLTRVGRMKMNHKLDIEVPDYVTVLTHEDIICTVKYLIRVK NGQGHIDDRDHLGNRRIRAIGELLANELHTGLVKMQKAIRDKLTTMSGNL DELMPHDLVNSKMITSTILEFFTGGQLSQFMDQTNPLSEVTHKRRLSALG EGGLVKERAGFEVRDVHPTHYGRICPIETPEGQNIGLINTLSTYSKVNDL GFIEAPYKKVIEGKVTDEVVYLTATQEEGLVIAPASTVLETDGAIKEDLI ETRIDGEIVLSEKSKVDLIDLSPGMVVGVAASLIPFLEHDDANRALMGSN MQRQAVPLLNPDAPVVGTGMEKTVARDSWEAIKATRGGIVEKVDAKNIYI LGEDENGAYIDHYSLQKNLRTNQNTCFSQAPIVHEGETIEAGQVIADGPN MDKGELALGKNIRVAFMPWNGYNFEDAIVVSEKLIREDTFTSIHIYEKEI EARELKHGVEEITRDIPNVREEELAHLDESGIVKIGTFVNAGMILVGKVS PKGEVKPTPEERLLRAIFGEKAGHVVNKSLYCPPSLEGTVVDVKIFTKKG YDKDQRAIAAYEEEKARLDLEHHDKLMMLDREEMLRLTSMLSKEPLASDV VVNEKSYKKGELIEKGDLAKINRFAMNALVKSFPKSIQEAYDQLKSNFLE QKKNLSEEHEEKLSVLEKDDILPSGVVKLVKIYVATKRKLKVGDKMAGRH GNKGIVSNIVREIDMPYTKDGEPVEIVLNPLGVPSRMNIGQILEVHLGLV GKKLGAQINEMFENQTKDWMGALRAKIIEIAQVSKMTGVDEFVSSLSDEA LLSYARDWRRGVKFATPVFEGVNEEEFTKLFELARIDTDGKTELYDGKTG AKMKERVNVGYMYMLKLHHLVDEKVHARSTGPYSLVTQQPVGGKALFGGQ RFGEMEVWALEAYGAAHTLKEMLTVKSDDVEGRVKAYKAITRGEPVKESE IPETFYVLTKELQSLALDVTVYGETEEDSFVPMPIKEDDRPSDFNAFQLM LASPDKIMSWSNGEVKKPETINYRTLKPERDGLFCAKIFGPVRDYECLCG KYKKMRYKGVVCEKCGVEVTSSKVRRSRMGHIELVTPVAHIWYVNSLPSR IGTLLGVKMKDLERVLYYEAYIVKTPGEAFYDNEGTKPVAKYDVLNEEQY QSLNQRFEHTGFVAQMGGEAVKELLAQIDLVELLHTLREEIKATNSEAKK KTIIKRLKVVESFINSGNRPEWMMLTVLPVLPPDLRPLVALDGGKFAVSD VNDLYRRVINRNQRLKRLMELDAPEIIIRNEKRMLQEAVDALFDNGRNAN AVKGANKRPLKSLSEIIKGKQGRFRQNLLGKRVDFSGRSVIVVGPNLRMD QCGLPKGMALELFKPHILAKLEEKGYATTLKQAKKMIEQKTNEVWECLQE IVEGYPIMLNRAPTLHKQSIQAFHPKLIDGKAIQLHPLVCSAFNADFDGD QMAVHVPLSQEAITECKLLMLSSMNILLPASGKAVTVPSQDMVLGLYYLS LAKEGSRGEHKLFSNVDEIMIALDADAVEINTKIRTIVDRRPLYTTVGRM IIKSILPDFVPVSLWNKVLKKKDIAALIDHVYKEGGLGITARFLDNLKDL GFKYATTAGISISSDDIRVPDIKRKTVEAAKKKVKEIQAQFGAGLLTEQE RYNKIIDVWTDTNNGLGSEMMKLVQADKGGFNSIYMMADSGARGSAAQIR QLSAMRGLMAKPDGTIIETPIISNFKEGLNVLEYFISTHGARKGLADTAL KTANAGYLTRKLIDVSQNVKIVMEDCGTHEGVEITDIAIGSELIEPLEER IFGRVVAEDVIDPITNEILVSEGSLIDEEMAKKIKEAGVKAVIIRTPVTC KAEKGVCSKCYGLNLGEGKVTNPGEAVGVVAAQSIGEPGTQLTLRTFHIG GTASRSQEERQVVVEKEGFIRYYNIKTYKNKEGKTVVANRRNAAVLLVEP KIKAPFEGELRVDTAHEEMVISVIGKSETVRYSLRKSDVAKPNELAGVTG KIEGKFYIPYGSGTKVREDGSIVEIIKDGWNIPNRIPYASELKVEDNAPI TQKIFSKEKGIVKYYRLKGDHLERYKEITKGEKVTEKGIFAVIADTNDRE AIRHYIARGSIIELADGAEVKPDSLVASPASSEQIVIADWDPYSNPIIAE EAGVVKYEDIIPGVTVTEQVDELTGQSRLVVNEYLPTSFKPTIVVASAAG NLIRYALDSKTAIFVGDGAEVEVADVLAKTPKALAKSKDITGGLPRVSEL FEARKPKDPAVLAEIDGVVSFGKPIRGKERIIITADDGRTTEYAVDKSKH ILVHHGEFVHAGESITDGIVSSHDILRISGEKELHKYIVSEVQQVYRRQG VNIADKHIEIIVSQMLRQVRIVDSGNTKFIEGDLVSKRHFKEENERTIRL GGEPAIAEPVLLGITRAAIGSDSIISAASFQETTKVLTEASIAAKIDFLE DLKENVVLGRMIPVGTGIYKNKKIRIKEKTEGA >WS1890 RPOD, RNA POLYMERASE SIGMA FACTOR MSAKNLTQELENLFKKSEAKYVSYEKIVQTFPKPPTAAQAKKVHELSVKY DKMLLSASEVAKLLNREEEKKIEDEKKRLLDEELEDEFDFMKERELLEWS RSDSPVRMYLREMGQIPLLTKDEEIELSKNIELGENIILDAICSVPYLID FILDYKEALINRERRVKELFKSFEDEEGGEEEEDEEVEEEADEEGEESKK PISKKDQKRVEKVLVSFKALEKAKKDWLKTLEGGAAQEEEGEFVELLHLL TLAYKKQTLKERLLDLGPTSKLINELVKAMENTLRNDEGFDRELKRLEYK LPLFNETLLENHQKILENITEMSKNDIASAVPEATMVSTYMEIKKLFQTK QASEESFDLEPEKLKEILEQIKRGKDIADKAKTKMAKSNLRLVVSIAKRY TNRGLPFLDLIQEGNIGLMKAVDKFEYKKGYKFSTYATWWIRQAISRAIA DQARTIRIPIHMIETINRINKIIRKYLQEEGKEPDVETISEEVGLPVDKV KNVIKITKEPISLEAPIGSDEDGKFGDFVEDKSSVGPMDHILKEDLKTQI DEVLDQLNEREKAVIRMRFGLLEDESDRTLEEIGKELNVTRERVRQIESS AIKKLKHPKVGRKLKNYIED >WS2100 RPON, RNA POLYMERASE SIGMA-54 FACTOR MKLRQSLQNKTKLSATLKSWLPILQSGLSDLEETLGEFTSENPYIEVQSK IETNLSSKIPKKSLERAPKNSLSEKIEALTIQEDSLYDILYEQIAPPLFP TATSQKIALKIIENLNEEGYFEGEIEKIALECESSSESCEKIRQRFSRLE PPGIGAKDVRESFLFQLDSSECDDELFSLVRELIEELEYHTRYKNHPRYV EAMRLIRSFKNPPAIDFFEKEPDIIPDLFVHDSSGQIEVRLNDAYYPTIV LDTARADKKHEYVKAKIKEAKDLIDALDMRKATLYKIGLMILEYQYDFFM GGEIRPMKLKDLAEEFNHAPSTISRAIASKYLECNRGIFSLKSFFSTAID EETSNAAIKDYIADMVKNEERGKPLSDIKILQNVENKFGIKMVRRTITKY RKQLNIASSSERKKLYEISV >WS1381 RPON, RNA POLYMERASE SIGMA-54 FACTOR MQSLRISQKQALRLSVRQWCAVLEASGSELEKKLSEAALENPFLKFRRKS LPTFSSGDFIENSPKERFLQESLLDQIDSSFFPTEFSQKIAAKIIEELNV EGYFEGDESAIAEEFGTSEAEVEKIRKRFRKLDPCGVGAKDSLEAFEFRL LESDYDEDLSSLAYEILRSPGQIHHLQGQARLLEAIDLAKRFSAPPALEF MQGEAFRRPDILVAEDEGVFRIEVWGDEFELGVEACGVKEKNSLKKEARL LCDYFNMRHSTLRKIATLIVDLQRDFFQGGELRPFSVSQAALEIGISQPT FSRAIAQKSLCCSRGTFPLRKFFPYEAKNGVSGEEIRAFIKALIAQEQGG RIYSDEQLSELVKRKFGVHIVRRTIGKYREQLGIPSPNFRKKLQGLKVKS LAVS >WS0240 SPOT, GUANOSINE-PYROPHOSPHOHYDROLASE MEFFSRVSKISSTAKAKELLFSLIEVTPPVQRAIDFAIEAHEGQKRKSGD PYVVHPLLVSCIVAYYGGDEAMICASLLHDVVEDTNFSTEDVSRIFGEDV ASLVDGLTKIVEIREEELPPAASNQKLVAAALSFRKMLIASIKDIRALVI KLCDRLHNMLTLDALPEKKRIRISEETLVVYAPIAHRLGISSMKNELEDR SFNYIFPEEYKKIDDYFHQNRQAIQLKLHTFIDKVKHLLMSKGMPDSDFV ITSRIKRHYSIYLKMQRKGISIEEVLDLLAIRIIVKEPLDCYKALGILHL EFKPIVSRFKDYVALPKENGYQTIHTTLFDDSSIFEVQVRTEDMHKSAEY GVAAHWKYKTGGITPSLGWLSDLQFQNNTIEEFYELVKNDLYREDITVFS PDGDTYTLPSGAVALDFAYAVHTEVGNCAKEAYVNNQKVSLLTVLKSGDI VRIITSKEPIVRASWVDAVKTSRAKNQIRVNCAIKLKEIEKRSAINIVAT IFGKLPEEIAAFVSNTHLESSIHKACKDLSYLKEIKNRINNSIRKDASLL TRIKIKILKLKEFIFDNLVIHSNYNINEALFDYCCHPKYGDEIVALKSGS KAFVHHKLCDRAYGEIEKGAKMLYVEWVKDKMASYKVIVALENQKGVLAN FLQFLAKNDINVLGVDLGSQKNSYASHCEVQIESHIKDAKLLRNILAQRF RIIDLYSQKDAYGSN >WS0990 VCA1001, TRANSCRIPTIONAL REGULATOR, ARAC/XYLS FAMILY MKLHQGERVSFVKTIPSLQETEFSRLEERLCFAKHAHPTYSIGIMPLGLS LCQGEGETYFMGRHKVCVYHPGEEHTCVFEHTGGSWAYWNCYPKEEMLRE YASEILGERGEPHFAKTVVEDPYAYRLFWELFDLVGKERELLALQEASLK AFSYLIAHHASPWHPSSRFLLMERAKITQAKERILEGDEVEKITLEELAS LCGMSRFRFLRLFAKLEGMTPHRFLLMHKTQKAKRYLQEGCDISEAALLS GFCDQAHLSRTLRRFYGYTPRSLRS >WS1155 YBFI, YBFI PROTEIN MPFLEIRLTKESGRIYEEHSHPMLSIGVMLEGETQFFLQGEEFRLQTGML AVIPPRMAHACNPLPSQTRSYFILHLSLDFCLEIQGRLFNEGGQNLLPLR APRIFDPMMYQGLTSLIQSLLKGYDSLKGEAFWGWCERFFARYTLEVSSR GDALISEVAEYLEGDVEEASLAFLSKRFQINPYTLERRFKKAYGTTPKRY HTDARLHRLKKLLRQGIPLALCAQYGGFSDQSHFQRFFKRRVALTPREYQ LNFVQ >WS0784 aspB, PUTATIVE AMINOTRANSFERASE PROTEIN MQRSFIREILEAISPQTLSLAGGLPDESLFPLQALSHCAQKVLSQPHSLQ YSISQGLPVLREKIAQHYSELGFPTNVDEILITTGAQQALDLLSKALASS GLIVESPAYLGAIGAFKSNQIPLVEIEMEEDGIELESLRAKLPKHRLAYL MSDFQNPTSRRYSLSKRQEIARLIESSEAILIEDGAYNELYFKERFPSIS SLIPHRSFHVGTFSKILSPSLRVGFIRASKENLAKILPYKESMDLHTSGI TQGIVNAFWEEYDFKAHKEKIRHAYALKAKALAQALQTHCPSFSFKEPEG GMFIYGSFAKGVDARALAFDSLKQGAVFVPGGEFYLQRRQSPEARLNFTH LDPRSLDLGVQIIAQTLRAQTKQ >WS0307 hemH, hypothetical protein MDLNEIIEKLKDILSEEKEGQKVLDRDVALALHIHPQSFACMKSRQKIPY EEILAFCAKRKISANWLFYNQAPESLIDTTNQYCYIRYFSQVHASAGGGA FNDTEACERIKLDAFWVERLGGEKEIKQIEAIAVTGDSMEPTLEDGDLIF IHRQKRQISKGGIFVIQTPHGIFVKRLQERLDGGVDILSDNSLYPTQTLE RDGIEVIGRVVGALKNLE >WS0842 plsC, hypothetical protein MFEGDFSTKELSCFYATIGLNVKKIRTKKKKSQLELALGHSSASFIAKAE IGIEGKHFNLEHLYKISKILEVDIRDFLTSPLEEDLIPSSPILC >WS1533 rpoB, TRANSCRIPTIONAL REGULATOR MASILRSSILSGEIAQGESITLDGIGEQVGMSRTPVREAFQILASEGLLE LRPNRCAIVKGISPDTIRDHYELRMILETEALKRACERMTSEDLASLEEI NQQGKLAKARGDVSTYNLINQAFHMVIWTAAGSEKLKHFLSLLWNGLSMN KRITAQEYATTSQDEHSEILEKILQKDSQGACHLMREHIRHSMESMLMNF HKEDEARS